Successful Treatment of Methicillin Susceptible Staphylococcus aureus Osteomyelitis with Oritavancin.

about

Multiple-Dose Oritavancin Evaluation in a Retrospective Cohort of Patients with Complicated Infections.

P2860

Q50091622-14816CB1-CFF9-4EFC-8660-513A3ACEDFEC

P2860

Successful Treatment of Methicillin Susceptible Staphylococcus aureus Osteomyelitis with Oritavancin.

Item

http://www.wikidata.org/entity/Q45059895

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Successful Treatment of Methic ...... steomyelitis with Oritavancin.

@en

Successful Treatment of Methic ...... steomyelitis with Oritavancin.

@nl

type

Item

label

Successful Treatment of Methic ...... steomyelitis with Oritavancin.

@en

Successful Treatment of Methic ...... steomyelitis with Oritavancin.

@nl

prefLabel

Successful Treatment of Methic ...... steomyelitis with Oritavancin.

@en

Successful Treatment of Methic ...... steomyelitis with Oritavancin.

@nl

P1476

Successful Treatment of Methic ...... steomyelitis with Oritavancin.

@en

P2093

Dino J Delaportas

http://www.w3.org/2001/XMLSchema#string

Matthew Darmelio

http://www.w3.org/2001/XMLSchema#string

Sandy J Estrada

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic antibiotic therapy for chronic osteomyelitis in adults

Extended-duration dosing and distribution of dalbavancin into bone and articular tissue.

Oritavancin population pharmacokinetics in healthy subjects and patients with complicated skin and skin structure infections or bacteremia.

Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based?

Serious infections caused by methicillin-resistant Staphylococcus aureus.

Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study.

Single-dose oritavancin in the treatment of acute bacterial skin infections.

Oritavancin Pharmacokinetics and Bone Penetration in Rabbits.

Distribution of radioactivity in bone and related structures following administration of [14C]dalbavancin to New Zealand white rabbits.

P304

e90-e92

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1957

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28543367

http://www.w3.org/2001/XMLSchema#string

Successful Treatment of Methicillin Susceptible Staphylococcus aureus Osteomyelitis with Oritavancin.

about

P2860

P2860

Successful Treatment of Methicillin Susceptible Staphylococcus aureus Osteomyelitis with Oritavancin.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698